Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Immunol. 2005 Nov;26(11):580-6. Epub 2005 Sep 15.

SLE: challenges and candidates in human disease.

Author information

1
Department of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, THT 429, 1530 3rd Avenue South, Birmingham, AL 35294-0006, USA.

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immunological hyperactivity and multi-system organ damage. A complex genetic trait involving multiple genes, with both genetic heterogeneity and a threshold effect for disease expression, SLE involves abnormalities of both the innate and adaptive immune systems. Recognition of an 'interferon signature' in SLE leukocytes, of the role of B cells in promoting disease activity, and of FCGR3A alleles as a biomarker of end organ damage, provide important insights into disease pathogenesis. Nonetheless, coordinated studies in humans and model systems hold promise for an even more rapid advance in understanding pathways of disease development and strategies for intervention. More effective markers of disease risk, disease activity, severity of organ damage and outcomes would facilitate earlier diagnosis and guide appropriately targeted treatment.

PMID:
16168709
DOI:
10.1016/j.it.2005.09.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center